Intravacc

Intravacc is a pioneering force in the vaccine development sector, founded in 2013 and headquartered in The Netherlands. With its slogan, Innovating vaccines to reduce human diseases, the company addresses the critical challenge of transforming promising vaccine concepts into viable products for large-scale production.

As an independent CDMO (Contract Development and Manufacturing Organization), Intravacc is strategically positioned within the Utrecht Science Park Bilthoven. The company reduces the inherent risks and costs of vaccine development by effectively bridging the gap between vaccine discovery and advanced clinical trials, specifically targeting phase I/II studies. Their extensive expertise offers clients a streamlined pathway from concept to clinical application.

Though details of their last investment are unavailable, Intravacc's strategic capabilities and established track record indicate a robust potential for growth and innovation in the rapidly evolving vaccine sector.